Medifast (MED) Non-Current Assets (2010 - 2026)

Medifast has reported Non-Current Assets for 17 years, with the latest figure at $49.4 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 25.68% year-over-year to $49.4 million; the trailing twelve-month figure through Mar 2026 stood at $219.0 million (down 19.43% YoY), and the FY2025 full-year result was $46.3 million, down 33.69% from the prior year.
• Non-Current Assets for Q1 2026 stood at $49.4 million, up from $46.3 million in the prior quarter.
• The five-year high for Non-Current Assets was $97.2 million in Q2 2022, with the low at $46.3 million in Q4 2025.
• Historically, Non-Current Assets has averaged $77.7 million across 5 years, with a median of $83.2 million in 2024.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 118.21% — and 2025, when it slumped 33.69%.
• Medifast's Non-Current Assets stood at $93.4 million in 2022, then fell by 8.08% to $85.9 million in 2023, then decreased by 18.71% to $69.8 million in 2024, then tumbled by 33.69% to $46.3 million in 2025, then gained by 6.75% to $49.4 million in 2026.
• The last three Non-Current Assets figures came in at $49.4 million (Q1 2026), $46.3 million (Q4 2025), and $60.4 million (Q3 2025), per Business Quant data.